Clinical Trial: Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Urinary Ascorbyl Peroxide as an Early Biological Marker of Bronchopulmonary Dysplasia in Preterm Infants Less Than 33 Weeks of Gestation

Brief Summary: Urinary ascorbyl peroxide level in the first week of life will be a good predictor of Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.